Please use the arrows to navigate to the sub pages
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys® technology.
Futura Medical is developing a portfolio of innovative products for two large markets, sexual health and pain.
Futura has a proven track record in delivery and completion of Research & Development projects up to value inflection points at which they are suitable for commercialisation partners.
Videos and webcasts
This section contains the latest RNS, news and videos.
The Company does not hold any Ordinary Shares in treasury and therefore the number of Ordinary Shares with voting rights is 287,070,977.
There are no restrictions on the transfer of Futura Medical plc shares.
Shareholders holding more than 3% of the share capital of Futura were:
Details of share options issued can be obtained from the Company's Annual Report 2020 which can be found in the Corporate Documentation.